Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy

Cell Biology International

Volumn 39, Issue 1, 2015, Pages 23-34

  Naderi Meshkin, Hojjat ^a   Bahrami, Ahmad Reza ^b   Bidkhori, Hamid Reza ^a,b   Mirahmadi, Mahdi ^a   Ahmadiankia, Naghmeh ^c  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

^c SHAHROUD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chemokine receptors; Homing; Mesenchymal stem cells; Preconditioning; Therapy

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; COBALT CHLORIDE; CYTOKINE; DEFEROXAMINE; GROWTH FACTOR; HYDRALAZINE; HYPOXIA INDUCIBLE FACTOR; LITHIUM; MOLECULAR SCAFFOLD; SIALYL LEWIS X ANTIGEN; SIGNAL PEPTIDE; STREPTAVIDIN; STROMAL CELL DERIVED FACTOR 1; VALPROIC ACID;

ANIMAL; BIOLOGICAL THERAPY; BRAIN ISCHEMIA; CELL ENGINEERING; CELL HOMING; CELL HYPOXIA; CELL MIGRATION; CELL MOTION; CELL SURFACE; CELL SURVIVAL; CYTOLOGY; DNA MODIFICATION; ELECTRIC FIELD; ENGRAFTMENT; GENETIC TRANSFECTION; GLYCOENGINEERING; HEART MUSCLE ISCHEMIA; HUMAN; LIMB ISCHEMIA; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; NEURAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; SPINAL CORD INJURY; STEM CELL MOBILIZATION; THERAPY; TISSUE REGENERATION; WOUNDS AND INJURIES;

ANIMALS; CELL HYPOXIA; CELL MOVEMENT; CELL- AND TISSUE-BASED THERAPY; CYTOKINES; CYTOLOGY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; METABOLISM; RECEPTORS, CHEMOKINE; THERAPY; WOUNDS AND INJURIES;

EID: 84945529820     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10378     Document Type: Review

References (114)

1. Ahmadian Kia N, Bahrami AR, EbrahimiM,Matin MM, Neshati Z, Almohaddesin MR, Aghdami N, Bidkhori HR (2011) Comparative analysis of chemokine receptor's expression in mesenchymal stem cells derived from human bone marrow and adipose tissue. J Mol Neurosci 44(3): 178-85.
2. Alon R, Kassner PD, Carr MW, Finger EB, Hemler ME, Springer A (1995) The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol 128(6): 1243-53.
3. Babona-Pilipos R, Droujinine IA, Popovic MR, Morshead CM (2011) Adult subependymal neural precursors, but not differentiated cells, undergo rapid cathodal migration in the presence of direct current electric fields. PLoS ONE 6(8): e23808.
4. Baek SJ, Kang SK, Ra C (2011) In vitro migration capacity of human adipose tissue-derived mesenchymal stem cells reflects their expression of receptors for chemokines and growth factors. Exp Mol Med 43(10): 596-603.
5. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, Miller L, Guetta E, Zipori D, Kedes LH, Kloner RA, Leor J (2003) Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108(7): 863-8.
6. Bekeredjian R, Grayburn PA, Shohet RV (2005) Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol 45(3): 329-35.
7. Binger T, Stich S, Andreas K, Kaps C, Sezer O, Notter M, Sittinger M, Ringe J (2009) Migration potential and gene expression profile of human mesenchymal stem cells induced by CCL25. Exp Cell Res 315(8): 1468-79.
8. Blumenthal B, Poppe A, Golsong P, Blanke P, Rylski B, Beyersdorf F, Schlensak C, Siepe M (2011) Functional regeneration of ischemic myocardium by transplanted cells overexpressing stromal cell-derived factor-1 (SDF-1): intramyocardial injection versus scaffold-based application. Eur J Cardiothorac Surg 40(4): e135-e141.
9. Bobis-Wozowicz S, Miekus K, Wybieralska E, Jarocha D, Zawisz A, Madeja Z, M (2011) Genetically modified adipose tissue-derived mesenchymal stem cells overexpressing CXCR4 display increased motility, invasiveness, and homing to bone marrow of NOD/SCID mice. Exp Hematol 39(6): 686-96 e684.
10. Borgens RB (1988) Stimulation of neuronal regeneration and development by steady electrical fields. Adv Neurol 47: 547-64.
11. Caplan AI, Correa D (2011) The MSC: an injury drugstore. Cell Stem Cell 9(1): 11-5.
12. Charwat S, Gyongyosi M, Lang I, Graf S, Beran G, Hemetsberger R, Nyolczas N, Sochor H, Glogar D (2008) Role of adult bone marrow stem cells in the repair of ischemic myocardium: current state of the art. Exp Hematol 36(6): 672-80.
13. Chu K, Jung KH, Kim SJ, Lee ST, Kim J, Park HK, Song EC, Kim SU, Kim M, Lee SK, Roh K (2008) Transplantation of human neural stem cells protect against ischemia in a preventive mode via hypoxia-inducible factor-1alpha stabilization in the host brain. Brain Res 1207: 182-92.
14. Dell'Accio F, De Bari C, Luyten P (2001) Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage. Arthritis Rheum 44(7): 1608-19.
15. Deng J, Zou ZM, Zhou TL, Su YP, Ai GP, Wang JP, Xu H, Dong W (2011) Bone marrow mesenchymal stem cells can be mobilized into peripheral blood by G-CSF in vivo and integrate into traumatically injured cerebral tissue. Neurol Sci 32(4): 641-51.
16. Di Rocco G, Gentile A, Antonini A, Ceradini F, Wu JC, Capogrossi MC, Toietta G (2010) Enhanced healing of diabetic wounds by topical administration of adipose tissue-derived stromal cells overexpressing stromal-derived factor-1: biodistribution and engraftment analysis by bioluminescent imaging. Stem Cells Int 2011: 304562.
17. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4): 315-7.
18. Edalatmanesh MA, Bahrami AR, Hosseini E, Hosseini M, Khatamsaz S (2011) Bone marrow derived mesenchymal stem cell transplantation in cerebellar degeneration: a behavioral study. Behav Brain Res 225(1): 63-70.
19. Edalatmanesh MA, Bahrami AR, Hosseini E, Hosseini M, Khatamsaz S (2011) Neuroprotective effects of mesenchymal stem cell transplantation in animal model of cerebellar degeneration. Neurol Res 33(9): 913-20.
20. Feng JF, Zhang XZ, Zhang L, Jiang JY, Nolta J, Zhao M (2012) Guided migration of neural stem cells derived from human embryonic stem cells by an electric field. Stem Cells 30(2): 349-55.
21. Fujii H, Li SH,Wu J,Miyagi Y, Yau TM, Rakowski H, Egashira K, Guo J, Weisel RD, Li K (2011) Repeated and targeted transfer of angiogenic plasmids into the infarcted rat heart via ultrasound targeted microbubble destruction enhances cardiac repair. Eur Heart J 32(16): 2075-84. doi: 10.1093/eurheartj/ehq475. Epub2010 Dec 31.
22. Futami I, Ishijima M, Kaneko H, Tsuji K, Ichikawa-Tomikawa N, Sadatsuki R, Muneta T, Arikawa-Hirasawa E, Sekiya I, Kaneko K (2012) Isolation and characterization of multipotential mesenchymal cells from the mouse synovium. PLoS ONE 7(9): e45517.
23. Gheisari Y, Azadmanesh K, Ahmadbeigi N, Nassiri SM, Golestaneh AF, Naderi M, Vasei M, Arefian E, Mirab-Samiee S, Shafiee A, Soleimani M, Zeinali S (2012) Genetic modification of mesenchymal stem cells to overexpress CXCR4 and CXCR7 does not improve the homing and therapeutic potentials of these cells in experimental acute kidney injury. Stem Cells Dev 21(16): 2969-80.
24. Goncalves RM (2012) Mesenchymal stem cell recruitment by stromal derived factor-1-delivery systems based on chitosan/ poly(gamma-glutamic acid) polyelectrolyte complexes. Eur Cell Mater 23: 249-60; discussion 241-260.
25. Griffin M, Iqbal SA, Sebastian A (2011) Degenerate wave and capacitive coupling increase human MSC invasion and proliferation while reducing cytotoxicity in an in vitro wound healing model. J Colthurst and A Bayat 6(8): e23404.
26. Gundlach C,W, Caivano T,A, Cabreira-Hansen Mda G, Gahremanpour A, BrownWS, Zheng Y, McIntyre BW,Willerson JT, Dixon RA, Perin EC, Woodside DG (2011) Synthesis and evaluation of an anti-MLC1 x anti-CD90 bispecific antibody for targeting and retaining bone-marrow-derived multipotent stromal cells in infarcted myocardium. Bioconjug Chem 22 (8): 1706-14.
27. Haddad-Mashadrizeh A, Bahrami AR, Matin MM, Edalatmanesh MA, Zomorodipour A, Fallah A, Gardaneh M, Ahmadian N, Sanjarmoosavi N (2013) Evidence for crossing the blood barrier of adult rat brain by human adipose-derived mesenchymal stromal cells during a 6-month period of posttransplantation. Cytotherapy 15(8): 951-60.
28. He X, Ma J, Jabbari E (2010) Migration of marrow stromal cells in response to sustained release of stromal-derived factor-1alpha from poly(lactide ethylene oxide fumarate) hydrogels. Int J Pharm 390(2): 107-16.
29. Hoenig MR, Bianchi C, SellkeW(2008) Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis. Curr Drug Targets 9(5): 422-35.
30. Hu X, Dai S,WuWJ, Tan W, Zhu X, Mu J, Guo Y, Bolli R, Rokosh G (2007) Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation 116(6): 654-63.
31. Hu X, Wei L, Taylor TM,Wei J, Zhou X, Wang JA, Yu SP (2011) Hypoxic preconditioning enhances bone marrow mesenchymal stem cell migration via Kv2. 1 channel and FAK activation. Am J Physiol Cell Physiol 301(2): C362-C372.
32. Huang AH, Yeger-McKeever M, Stein A, Mauck L (2008) Tensile properties of engineered cartilage formed from chondrocyteand MSC-laden hydrogels. Osteoarthritis Cartilage 16(9): 1074-82.
33. Huang YS, Li IH, Chueh SH, Hueng DY, Tai MC, Liang CM, Lien SB, Sytwu HK, Ma H (2013) Mesenchymal stem cells from rat olfactory bulbs can differentiate into cells with cardiomyocyte characteristics. J Tissue Eng Regen Med doi: 10.1002/ term.1684.
34. Hung SC, Pochampally RR, Hsu SC, Sanchez C, Chen SC (2007) Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. J Spees and D J Prockop 2(5): e416.
35. Jacobsen K, Kravitz J, Kincade PW, Osmond G (1996) Adhesion receptors on bone marrow stromal cells: in vivo expression of vascular cell adhesion molecule-1 by reticular cells and sinusoidal endothelium in normal and gamma-irradiated mice. Blood 87(1): 73-82.
36. Karimabad HM, Shabestari M, Baharvand H, Vosough A, Gourabi H, Shahverdi A, Shamsian A, Abdolhoseini S, Moazzami K, Marjanimehr MM, Emami F, Bidkhori HR, Hamedanchi A, Talebi S, Farrokhi F, Jabbari-Azad F, Fadavi M, Garivani U, Mahmoodi M, Aghdami N (2011) Lack of beneficial effects of granulocyte colony-stimulating factor in patients with subacute myocardial infarction undergoing late revascularization: a double-blind, randomized, placebo-controlled clinical trial. Acta Cardiol 66(2): 219-24.
37. Karp JM, Leng Teo S (2009) Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 4(3): 206-16.
38. Kimura Y, Tabata Y (2010) Controlled release of stromal-cellderived factor-1 from gelatin hydrogels enhances angiogenesis. J Biomater Sci Polym Ed 21(1): 37-51.
39. Knowles HJ, Tian YM, Mole DR, Harris L (2004) Novel mechanism of action for hydralazine: induction of hypoxiainducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases. Circ Res 95(2): 162-9.
40. Ko IK, Kean TJ, Dennis E (2009) Targeting mesenchymal stem cells to activated endothelial cells. Biomaterials 30(22): 3702-10.
41. Ko IK, Kim BG, Awadallah A, Mikulan J, Lin P, Letterio JJ, Dennis JE (2010) Targeting improves MSC treatment of inflammatory bowel disease. Mol Ther 18(7): 1365-72.
42. Komarova S, Roth J, Alvarez R, Curiel DT, Pereboeva L (2010) Targeting of mesenchymal stem cells to ovarian tumors via an artificial receptor. J Ovarian Res 3: 12. doi: 10.1186/1757-2215-3-12.
43. Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, Zhang J, Ratajczak J, Ratajczak MZ (2004) CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35(3): 233-45.
44. Kumar S, Ponnazhagan S (2007) Bone homing of mesenchymal stem cells by ectopic alpha 4 integrin expression. Faseb J 21(14): 3917-27.
45. LaBarge MA, Blau M (2002) Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 111(4): 589-601.
46. Larsen S, Lewis D (2011) Potential therapeutic applications of mesenchymal stromal cells. Pathology 43(6): 592-604.
47. Lazennec G, Richmond A (2010) Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 16(3): 133-44.
48. Li L, El-Hayek YH, Liu B, Chen Y, Gomez E, Wu X, Ning K, Chang N, Zhang L, Wang Z, Hu X, Wan Q (2008) Directcurrent electrical field guides neuronal stem/progenitor cell migration. Stem Cells 26(8): 2193-200.
49. Liu H, Liu S, Li Y, Wang X, Xue W, Ge G, Luo X (2012) The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury. PLoS One 7(4): e34608.
50. Liu H, Xue W, Ge G, Luo X, Li Y, Xiang H, Ding X, Tian P, Tian X (2010) Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1alpha in MSCs. Biochem Biophys Res Commun 401(4): 509-15.
51. Luster AD, Alon R, von Andrian UH (2005) Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 6(12): 1182-90.
52. Lyn D, Liu X, Bennett NA, Emmett L (2000) Gene expression profile in mouse myocardium after ischemia. Physiol Genomics 2(3): 93-100.
53. Makinen S, Kekarainen T, Nystedt J, Liimatainen T, Huhtala T, Narvanen A, Laine J, Jolkkonen J (2006) Human umbilical cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats. Brain Res 1123(1): 207-15.
54. Mamalis AA, Cochran L (2011) The therapeutic potential of oxygen tension manipulation via hypoxia inducible factors and mimicking agents in guided bone regeneration. A review Arch Oral Biol 56(12): 1466-75.
55. McCaig CD, Rajnicek AM, Song B, Zhao M (2005) Controlling cell behavior electrically: current views and future potential. Physiol Rev 85(3): 943-78.
56. Mimeault M, Batra K (2013) Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer-and metastasis-initiating cells. J Cell Mol Med 17(1): 30-54.
57. Mundra V, Gerling IC, Mahato I (2013) Me senchymal stem cellbased therapy. Mol Pharm 10(1): 77-89.
58. Naderi-Meshkin H, Andreas K, MatinMM, Sittinger M, Bidkhori HR, Ahmadiankia N, Bahrami AR, Ringe J (2014) Chitosanbased injectable hydrogel as a promising in situ forming scaffold for cartilage tissue engineering. Cell Biol Int 38(1): 72-84.
59. Najafi R, Sharifi M (2013) Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats. Expert Opin Biol Ther 13(7): 959-72.
60. Nuccitelli R (2003) Endogenous electric fields in embryos during development, regeneration and wound healing. Radiat Prot Dosimetry 106(4): 375-83.
61. Ohnishi S, Nagaya N (2007) Prepare cells to repair the heart: mesenchymal stem cells for the treatment of heart failure. Am J Nephrol 27(3): 301-7.
62. Pasha Z, Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M (2008) Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 77(1): 134-42.
63. PennMS,MendelsohnFO,SchaerGL, ShermanW,FarrM,Pastore J, Rouy D, Clemens R, Aras R, LosordoW(2013) An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure. Circ Res 112(5): 816-25.
64. Phipps MC, Xu Y, Bellis L (2012) Delivery of platelet-derived growth factor as a chemotactic factor for mesenchymal stem cells by bone-mimetic electrospun scaffolds. PLoS One 7(7): e40831.
65. Poloni A, Maurizi G, Serrani F, Mancini S, Zingaretti MC, Frontini A, Cinti S, Olivieri A, Leoni P (2013) Molecular and functional characterization of human bone marrow adipocytes. Exp Hematol 41(6): 558-66.
66. Rosova I, Dao M, Capoccia B, Link D, Nolta A (2008) Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26(8): 2173-82.
67. Ryser MF, Ugarte F, Thieme S, Bornhauser M, Roesen-Wolff A, Brenner S (2008) MRNA transfection of CXCR4-GFP fusion-simply generated by PCR-results in efficient migration of primary human mesenchymal stem cells. Tissue Eng Part C Methods 14(3): 179-84.
68. Sackstein R (2009) Glycosyltransferase-programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migration. Immunol Rev 230(1): 51-74.
69. Sackstein R (2011) The biology of CD44 and HCELL in hematopoiesis: the 'step 2-bypass pathway' and other emerging perspectives. Curr Opin Hematol 18(4): 239-48.
70. Sackstein R (2012) Engineering cellular trafficking via glycosyltransferase-programmed stereosubstitution. Ann N Y Acad Sci 1253: 193-200.
71. Sackstein R (2012) Glycoengineering of HCELL, the human bone marrow homing receptor: sweetly programming cell migration. Ann Biomed Eng 40(4): 766-76.
72. Sackstein R, Merzaban JS, Cain DW, Dagia NM, Spencer JA, Lin CP, Wohlgemuth R (2008) Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med 14(2): 181-7.
73. Sarkar D, Vemula PK, Teo GS, Spelke D, Karnik R, Wee Y, Karp M (2008) Chemical engineering of mesenchymal stem cells to induce a cell rolling response. Bioconjug Chem 19(11): 2105-9.
74. Sarkar D, Vemula PK, Zhao W, Gupta A, Karnik R, Karp M (2010) Engineered mesenchymal stem cells with self-assembled vesicles for systemic cell targeting. Biomaterials 31(19): 5266-74.
75. Sarkar D, Zhao W, Gupta A, Loh WL, Karnik R, Karp M (2011a) Cell surface engineering of mesenchymal stem cells. Methods Mol Biol 698: 505-23.
76. Sarkar D, Spencer JA, Phillips JA, Zhao W, Schafer S, Spelke DP, Mortensen LJ, Ruiz JP, Vemula PK, Sridharan R, Kumar S, Karnik R, Lin CP, Karp M (2011b) Engineered cell homing. Blood; 15;118(25):e 184-91.
77. Sasaki T, Fukazawa R, Ogawa S, Kanno S, Nitta T, Ochi M, Shimizu K (2007) Stromal cell-derived factor-1alpha improves infarcted heart function through angiogenesis in mice. Pediatr Int 49(6): 966-71.
78. Saxena A, Fish JE, White MD, Yu S, Smyth JW, Shaw RM, DiMaio JM, Srivastava D (2008) Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction. Circulation 117 (17): 2224-31.
79. Schantz JT, Chim H, Whiteman M (2007) Cell guidance in tissue engineering: SDF-1 mediates site-directed homing of mesenchymal stem cells within three-dimensional polycaprolactone scaffolds. Tissue Eng 13(11): 2615-24.
80. Schweitzer KM, Drager AM, P. van der Valk, Thijsen SF, Zevenbergen A, Theijsmeijer AP, van der Schoot CE, Langenhuijsen MM (1996) Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues. Am J Pathol 148(1): 165-75.
81. Segers VF, Revin V, Wu W, Qiu H, Yan Z, Lee RT, Sandrasagra A (2011) Protease-resistant stromal cell-derived factor-1 for the treatment of experimental peripheral artery disease. Circulation 123(12): 1306-15.
82. Segers VF, Tokunou T, Higgins LJ, MacGillivray C, Gannon J, Lee RT (2007) Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 116(15): 1683-92.
83. Sharma M, Afrin F, Satija N, Tripathi RP, Gangenahalli U (2011) Stromal-derived factor-1/CXCR4 signaling: indispensable role in homing and engraftment of hematopoietic stem cells in bone marrow. Stem Cells Dev 20(6): 933-46.
84. Sharp FR, Bernaudin M (2004) HIF1 and oxygen sensing in the brain. Nat Rev Neurosci 5(6): 437-48.
85. Shen W, Chen X, Chen J, Yin Z, Heng BC, Chen W, Ouyang W (2010) The effect of incorporation of exogenous stromal cellderived factor-1 alpha within a knitted silk-collagen sponge scaffold on tendon regeneration. Biomaterials 31(28): 7239-49.
86. Shi M, Li J, Liao L, Chen B, Li B, Chen L, Jia H, Zhao C (2007) Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/ SCID mice. Haematologica 92(7): 897-904.
87. Shinohara K, Greenfield S, Pan H, Vasanji A, Kumagai K, Midura RJ, Kiedrowski M, Penn MS, Muschler F (2011) Stromal cellderived factor-1 and monocyte chemotactic protein-3 improve recruitment of osteogenic cells into sites of musculoskeletal repair. J Orthop Res 29(7): 1064-9.
88. Simoes IN, Boura JS, Dos Santos F, Andrade PZ, Cardoso CM, Gimble JM, da Silva CL, Cabral M (2013) Human mesenchymal stem cells from the umbilical cord matrix: successful isolation and ex-vivo expansion using serum-/xeno-free culture media. Biotechnol J 8(4): 448-58.
89. Simon SI, Green E (2005) Molecular mechanics and dynamics of leukocyte recruitment during inflammation. Annu Rev Biomed Eng 7: 151-85.
90. Sordi V, Malosio ML, Marchesi F, Mercalli A, Melzi R, Giordano T, Belmonte N, Ferrari G, Leone BE, Bertuzzi F, Zerbini G, Allavena P, Bonifacio E, Piemonti L (2005) Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 106(2): 419-27.
91. Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76(2): 301-14.
92. Takada Y, Ye X, Simon S (2007) The integrins. Genome Biol 8(5): 215.
93. Tator CH (2005) Phase 1 trial of oscillating field stimulation for complete spinal cord injury in humans. JNeurosurg Spine 2(1): 1; discussion 1-2.
94. Thankamony SP, Sackstein R (2011) Enforced hematopoietic cell E-and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells. Proc Natl Acad Sci U S A 108(6): 2258-63.
95. Thevenot PT, Nair AM, Shen J, Lotfi P, Ko CY, Tang L (2010) The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials 31(14): 3997-4008.
96. Thieme S, Ryser M, Gentsch M, Navratiel K, Brenner S, Stiehler M, Rolfing J, Gelinsky M, Rosen-Wolff A (2009) Stromal cellderived factor-1alpha-directed chemoattraction of transiently CXCR4-overexpressing bone marrow stromal cells into functionalized three-dimensional biomimetic scaffolds. Tissue Eng Part C Methods 15(4): 687-96.
97. Tsai CC, Yew TL, Yang DC, Huang WH, Hung C (2012) Benefits of hypoxic culture on bone marrow multipotent stromal cells. Am J Blood Res 2(3): 148-59.
98. Tsai LK, Wang Z, Munasinghe J, Leng Y, Leeds P, Chuang DM (2011) Mesenchymal stem cells primed with valproate and lithium robustly migrate to infarcted regions and facilitate recovery in a stroke model. Stroke 42(10): 2932-9.
99. Wagner J, Kean T, Young R, Dennis JE, Caplan AI (2009) Optimizing mesenchymal stem cell-based therapeutics. Curr Opin Biotechnol 20(5): 531-6.
100. Walczak P, Zhang J, Gilad AA, Kedziorek DA, Ruiz-Cabello J, Young RG, Pittenger MF, van Zijl PC, Huang J, Bulte JW (2008) Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 39(5): 1569-74.
101. Wei N, Yu SP, Gu X, Taylor TM, Song D, Liu XF, Wei L (2013) Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice. Cell Transplant 22(6): 977-91.
102. Wiehe JM, Kaya Z, Homann JM, Wohrle J, Vogt K, Nguyen T, Rottbauer W, Torzewski J, Fekete N, Rojewski M, Schrezenmeier H, Moepps B, Zimmermann O (2012) GMP-adapted overexpression of CXCR4 in human mesenchymal stem cells for cardiac repair. Int J Cardiol 167(5): 2073-81.
103. Wu Y, Zaho C (2012) The role of chemokines in mesenchymal stem cell homing to myocardium. Stem Cell Rev 8(1): 243-50.
104. Wynn RF, Hart CA, Corradi-Perini C, O'Neill L, Evans CA, Wraith JE, Fairbairn LJ, Bellantuono I (2004) A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 104(9): 2643-5.
105. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, Bosch-Marce M, Masuda H, Losordo DW, Isner JM, Asahara T (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107 (9): 1322-8.
106. Yu X, Lu C, Liu H, Rao S, Cai J, Liu S, Kriegel AJ, Greene AS, Liang M, Ding X (2013) Hypoxic preconditioning with cobalt of bone marrow mesenchymal stem cells improves cell migration and enhances therapy for treatment of ischemic acute kidney injury. PLoS One 8(5): e62703.
107. Yue Y, Zhang P, Liu D, Yang JF, Nie C, Yang D (2013) Hypoxia preconditioning enhances the viability of ADSCs to increase the survival rate of ischemic skin flaps in rats. Aesthetic Plast Surg 37(1): 159-70.
108. Zhang D, Fan GC, Zhou X, Zhao T, Pasha Z, Xu M, Zhu Y, Ashraf M, Wang Y (2008) Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. J Mol Cell Cardiol 44(2): 281-92.
109. Zhang F, Leong W, Su K, Fang Y, Wang A (2013) A Transduced Living Hyaline Cartilage Graft Releasing Transgenic Stromal Cell-Derived Factor-1 Inducing Endogenous Stem Cell Homing In Vivo. Tissue Eng Part A 19(9-10): 1091-9.
110. Zhang J, Calafiore M, Zeng Q, Zhang X, Huang Y, Li RA, Deng W, Zhao M (2011) Electrically guiding migration of human induced pluripotent stem cells. Stem Cell Rev 7(4): 987-96.
111. Zhang M, Mal N, Kiedrowski M, Chacko M, Askari AT, Popovic ZB, Koc ON, Penn S (2007) SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J 21(12): 3197-207.
112. Zhang X, Bogorin DF, Moy T (2004) Molecular basis of the dynamic strength of the sialyl Lewis X-selectin interaction. Chemphyschem 5(2): 175-82.
113. Zhang X, Wang Y, Gao Y, Liu X, Bai T, Li M, Li L, Chi G, Xu H, Liu F, Liu JY, Li Y (2013) Maintenance of high proliferation and multipotent potential of human hair follicle-derived mesenchymal stem cells by growth factors. Int JMol Med 31(4): 913-21.
114. Zhao T, Zhang D, Millard RW, Ashraf M, Wang Y (2009) Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1alpha delivery and endogenous cytokine signaling. Am J Physiol Heart Circ Physiol 296(4): H976-986.